Gene: CAV1

857
BSCL3|CGL3|LCCNS|MSTP085|PPH3|VIP21
caveolin 1
protein-coding
7q31.2
Ensembl:ENSG00000105974 MIM:601047 Vega:OTTHUMG00000023413 UniprotKB:Q03135
NG_012051.1
PubMed
CD|ND|AD
6   
NA (AD)  NA (ND)   (Frontal_Cortex)
7.505e-2 (AD)  2.617e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
CAV20.828
MYCT10.807
MECOM0.803
TES0.802
EDNRA0.799
PALMD0.798
FOXC10.797
TGFBR20.796
VEGFC0.796
TGFB1I10.795

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
MYADML2-0.437
LRTM2-0.432
CYP46A1-0.42
MARCH4-0.418
KCNB2-0.416
LRFN2-0.409
CDK5R2-0.409
HAS1-0.409
SVOP-0.408
HIPK4-0.407

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C52148710-nitro-oleic acid10-nitro-oleic acid results in increased expression of CAV1 protein24140437
C0793931,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole"1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole results in decreased expression of CAV1 protein"19706615
C03864913-hydroperoxy-9,11-octadecadienoic acid"13-hydroperoxy-9,11-octadecadienoic acid results in increased expression of CAV1 mRNA"27257344
C1053511-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene"1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene results in increased expression of CAV1 protein"18717816
C1053511-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene"[Oxygen deficiency co-treated with 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene] results in increased expression of CAV1 protein"18717816
C0192732,2-bis(4-glycidyloxyphenyl)propane"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone results in increased expression of CAV1 protein]"16806087
C1202272-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide"2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide results in increased expression of CAV1 protein"19288272
C00358522-hydroxycholesterol22-hydroxycholesterol results in increased expression of CAV1 mRNA15314095
C0942102,2'-(hydroxynitrosohydrazono)bis-ethanamine"2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in decreased ubiquitination of and results in decreased degradation of CAV1 protein"19706615
C0942102,2'-(hydroxynitrosohydrazono)bis-ethanamine"2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CAV1 protein"19706615
C0942102,2'-(hydroxynitrosohydrazono)bis-ethanamine"2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased metabolism of and results in increased stability of CAV1 protein"19706615
C1111182',3,3',4',5-pentachloro-4-hydroxybiphenyl"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of CAV1 mRNA"19114083
C4574992-chloro-5-nitrobenzanilide2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA]15314095
C0312782-chloroethyl ethyl sulfide2-chloroethyl ethyl sulfide results in increased expression of CAV1 mRNA21457723
C0312782-chloroethyl ethyl sulfide2-chloroethyl ethyl sulfide results in increased expression of CAV1 protein21457723
C0312782-chloroethyl ethyl sulfide2-chloroethyl ethyl sulfide results in increased expression of CAV1 mRNA21457723
C0312782-chloroethyl ethyl sulfide2-chloroethyl ethyl sulfide results in increased expression of CAV1 protein21457723
C0312782-chloroethyl ethyl sulfideSB 203580 inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of CAV1 mRNA]21457723
C0312782-chloroethyl ethyl sulfideSB 203580 inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of CAV1 protein]21457723
C0284513,4,3',4'-tetrachlorobiphenyl"3,4,3',4'-tetrachlorobiphenyl promotes the reaction [CAV1 protein binds to AHR protein]"18786521
C0284513,4,3',4'-tetrachlorobiphenyl"3,4,3',4'-tetrachlorobiphenyl results in increased expression of CAV1 protein"18786521
C0284513,4,3',4'-tetrachlorobiphenyl"CAV1 mutant form inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of VCAM1 protein]"20406653
C0284513,4,3',4'-tetrachlorobiphenyl"CAV1 mutant form inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased phosphorylation of and results in increased activity of MAPK1 protein]"20406653
C0284513,4,3',4'-tetrachlorobiphenyl"CAV1 mutant form inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased phosphorylation of and results in increased activity of MAPK3 protein]"20406653
C0284513,4,3',4'-tetrachlorobiphenyl"CAV1 protein promotes the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A1 protein]"18786521
C0284513,4,3',4'-tetrachlorobiphenyl"3,4,3',4'-tetrachlorobiphenyl results in increased expression of and results in increased phosphorylation of CAV1 protein"19608276
C0284513,4,3',4'-tetrachlorobiphenyl"CAV1 mutant form inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of VCAM1 protein]"20406653
C0284513,4,3',4'-tetrachlorobiphenyl"Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of and results in increased phosphorylation of CAV1 protein]"19608276
C0284513,4,3',4'-tetrachlorobiphenyl"CAV1 protein affects the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased activity of NOS3 protein]"19265715
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CAV1 mRNA"28973690
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [CAV1 mutant form results in decreased expression of FYN protein]"24709675
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [CAV1 mutant form results in decreased expression of KEAP1 protein]"24709675
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [CAV1 mutant form results in decreased phosphorylation of PRKCD protein]"24709675
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [CAV1 mutant form results in increased phosphorylation of AKT1 protein]"24709675
C0230353,4,5,3',4'-pentachlorobiphenyl"CAV1 affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]"19265715
C0230353,4,5,3',4'-pentachlorobiphenyl"CAV1 affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 protein]"19265715
C0230353,4,5,3',4'-pentachlorobiphenyl"CAV1 affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL6 mRNA]"19265715
C0230353,4,5,3',4'-pentachlorobiphenyl"CAV1 affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL6 protein]"19265715
C0230353,4,5,3',4'-pentachlorobiphenyl"CAV1 gene mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 mRNA]"24709675
C0230353,4,5,3',4'-pentachlorobiphenyl"CAV1 gene mutant form promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of NQO1 protein]"24709675
C0230353,4,5,3',4'-pentachlorobiphenyl"CAV1 mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 protein]"20406653
C0230353,4,5,3',4'-pentachlorobiphenyl"CAV1 mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased phosphorylation of and results in increased activity of MAPK1 protein]"20406653
C0230353,4,5,3',4'-pentachlorobiphenyl"CAV1 mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased phosphorylation of and results in increased activity of MAPK3 protein]"20406653
C0230353,4,5,3',4'-pentachlorobiphenyl"CAV1 mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]"19265715
C0230353,4,5,3',4'-pentachlorobiphenyl"CAV1 mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 mRNA]"24709675
C0230353,4,5,3',4'-pentachlorobiphenyl"CAV1 mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 protein]"20406653
C0230353,4,5,3',4'-pentachlorobiphenyl"CAV1 mutant form promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of NQO1 mRNA]"24709675
C0095054,4'-diaminodiphenylmethane"4,4'-diaminodiphenylmethane results in increased expression of CAV1 mRNA"25380136
C0909424-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[Sulfasalazine results in decreased activity of SLC7A11 protein] which results in increased expression of CAV1 mRNA]19015640
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA"27188386
C1081234-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine"4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of CAV1 protein]"26357463
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA"27188386
D000082AcetaminophenAcetaminophen results in decreased expression of CAV1 mRNA21420995|2906747
D000082AcetaminophenAcetaminophen results in decreased expression of CAV1 protein20100502
D000082AcetaminophenCAV1 affects the reaction [Acetaminophen results in increased expression of BIRC5 protein]20100502
D000082AcetaminophenCAV1 affects the reaction [Acetaminophen results in increased expression of CCL2 mRNA]20100502
D000082AcetaminophenCAV1 affects the reaction [Acetaminophen results in increased expression of PCNA protein]20100502
D000082AcetaminophenCAV1 affects the reaction [Acetaminophen results in increased expression of PTGS2 protein]20100502
D000082AcetaminophenCAV1 results in increased susceptibility to Acetaminophen20100502
D000109Acetylcholine"Sodium, Dietary affects the reaction [CAV1 protein affects the susceptibility to Acetylcholine]"18178722
D000111AcetylcysteineAcetylcysteine inhibits the reaction [rosiglitazone results in increased expression of CAV1]18507034
D000111AcetylcysteineAcetylcysteine results in decreased expression of CAV121148404
D000111AcetylcysteineAcetylcysteine results in increased ubiquitination of and results in increased degradation of CAV1 protein21148404
D000111AcetylcysteineHydrogen Peroxide inhibits the reaction [Acetylcysteine results in increased ubiquitination of and results in increased degradation of CAV1 protein]21148404
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of CAV1 mRNA27153756
C412373AG 1879AG 1879 inhibits the reaction [Lipopolysaccharides results in increased expression of CAV1 protein modified form]26357463
C412373AG 1879AG 1879 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of CAV1 protein]26357463
D000450AldosteroneAldosterone results in increased expression of CAV1 mRNA23426970
D000450AldosteroneAldosterone results in increased expression of CAV1 protein23426970
D000450AldosteroneMifepristone inhibits the reaction [Aldosterone results in increased expression of CAV1 mRNA]23426970
D000450AldosteroneSpironolactone inhibits the reaction [Aldosterone results in increased expression of CAV1 mRNA]23426970
D000497AlloysAlloys results in decreased expression of CAV1 mRNA23499988
D024502alpha-Tocopherolalpha-Tocopherol inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA]27257344
D000643Ammonium ChlorideAmmonium Chloride affects the expression of CAV1 mRNA16483693
D000643Ammonium ChlorideAmmonium Chloride results in decreased expression of CAV1 protein16483693
D000841AnisomycinAnisomycin results in increased phosphorylation of CAV1 protein23246481
D000841Anisomycinwogonin inhibits the reaction [Anisomycin results in increased phosphorylation of CAV1 protein]23246481
D018501Antirheumatic AgentsAntirheumatic Agents results in increased expression of CAV1 mRNA24449571
C006632arsenic trioxidearsenic trioxide results in decreased expression of CAV1 mRNA15725085|2623859
C006632arsenic trioxidearsenic trioxide results in decreased expression of CAV1 protein28521025
C006632arsenic trioxidearsenic trioxide results in increased expression of CAV1 mRNA22521957
C006632arsenic trioxidearsenic trioxide results in increased expression of CAV1 protein17512576
C015001arseniteCAV1 protein inhibits the reaction [arsenite results in increased phosphorylation of MAPK1 protein]12640124
C015001arseniteCAV1 protein inhibits the reaction [arsenite results in increased phosphorylation of MAPK3 protein]12640124
C015001arsenitearsenite results in increased phosphorylation of CAV1 protein14511371
C015001arsenitetyrphostin 25 inhibits the reaction [arsenite results in increased phosphorylation of CAV1 protein]14511371
D017636Asbestos, Amphibole"Asbestos, Amphibole results in increased expression of CAV1 mRNA"22352330
D001241AspirinAspirin results in decreased expression of CAV1 mRNA12800193
D001280AtrazineAtrazine results in increased expression of CAV1 mRNA22378314
D001280AtrazineAtrazine results in decreased expression of CAV1 mRNA27614199
C030935benz(a)anthracene[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA27858113
C006703benzo(b)fluoranthene[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA27858113
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of CAV1 mRNA20106945
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of CAV1 protein26657896
D001564Benzo(a)pyrene[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA27858113
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of CAV1 mRNA19770486
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of CAV1 mRNA22228805
D0151237,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CAV1 mRNA"19150397
C072553benzyloxycarbonylleucyl-leucyl-leucine aldehydebenzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CAV1 protein19706615
C072553benzyloxycarbonylleucyl-leucyl-leucine aldehyde[MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of CAV1 mRNA25566086
D019207beta Carotenebeta Carotene results in decreased expression of CAV1 protein26733226
D004958EstradiolEstradiol inhibits the reaction [ESR2 protein binds to CAV1 protein]18296501
D004958EstradiolEstradiol promotes the reaction [CAV1 protein modified form binds to CAV1 protein]18296501
D004958EstradiolEstradiol promotes the reaction [ESR1 protein binds to CAV1 protein]18296501
D004958EstradiolEstradiol promotes the reaction [ESR1 protein modified form binds to CAV1 protein]18296501
D004958EstradiolEstradiol promotes the reaction [SRC protein binds to CAV1 protein]18296501
D004958EstradiolEstradiol promotes the reaction [SRC protein modified form binds to CAV1 protein]18296501
D004958Estradiolfulvestrant inhibits the reaction [Estradiol promotes the reaction [CAV1 protein modified form binds to CAV1 protein]]18296501
D004958Estradiolfulvestrant inhibits the reaction [Estradiol promotes the reaction [ESR1 protein binds to CAV1 protein]]18296501
D004958Estradiolfulvestrant inhibits the reaction [Estradiol promotes the reaction [ESR1 protein modified form binds to CAV1 protein]]18296501
D004958Estradiolmethyl-beta-cyclodextrin inhibits the reaction [Estradiol promotes the reaction [CAV1 protein modified form binds to CAV1 protein]]18296501
D004958Estradiolmethyl-beta-cyclodextrin inhibits the reaction [Estradiol promotes the reaction [ESR1 protein binds to CAV1 protein]]18296501
D004958Estradiolmethyl-beta-cyclodextrin inhibits the reaction [Estradiol promotes the reaction [SRC protein modified form binds to CAV1 protein]]18296501
D004958Estradiol[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CAV1 mRNA19619570
D004958EstradiolEstradiol results in decreased expression of CAV1 mRNA19619570
D004958EstradiolEstradiol results in increased phosphorylation of CAV1 protein18296501
D004958Estradiol[Estradiol co-treated with Progesterone] results in decreased expression of CAV1 protein16436525
D004958EstradiolEstradiol results in decreased expression of CAV1 protein16436525
D004958EstradiolEstradiol results in decreased expression of CAV1 mRNA27174447
C006780bisphenol Abisphenol A inhibits the reaction [NOS3 protein binds to CAV1 protein]25663485
C006780bisphenol Abisphenol A promotes the reaction [XIAP protein binds to CAV1 protein]25663485
C006780bisphenol Abisphenol A affects the expression of CAV1 mRNA21786754
C006780bisphenol Abisphenol A affects the expression of CAV1 mRNA25181051
C006780bisphenol Abisphenol A inhibits the reaction [SIRT1 protein binds to CAV1 protein]28067316
C006780bisphenol Abisphenol A promotes the reaction [ESR2 protein binds to CAV1 protein]28067316
C006780bisphenol Abisphenol A results in decreased acetylation of CAV1 protein28067316
C006780bisphenol Abisphenol A results in decreased expression of CAV1 mRNA27174447
C006780bisphenol Abisphenol A results in decreased expression of CAV1 protein27174447
D001761BleomycinBleomycin results in decreased expression of CAV1 protein25933445
D020122tert-Butylhydroperoxidetert-Butylhydroperoxide results in increased expression of CAV1 mRNA15963989
D020148Butyric AcidButyric Acid results in decreased expression of CAV1 mRNA12800193
D002104CadmiumCadmium promotes the reaction [HMOX1 protein binds to CAV1 protein]14658758
D019256Cadmium ChlorideCadmium Chloride results in increased expression of CAV1 mRNA26472689
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of CAV1 mRNA23741332
C035196cadmium nitratecadmium nitrate results in decreased expression of CAV1 protein19061949
D002118CalciumCAV1 protein affects the transport of Calcium16428350
D002118CalciumCalcium inhibits the reaction [NOX2 protein binds to CAV1 protein]24835767
D002220CarbamazepineCarbamazepine affects the expression of CAV1 mRNA25979313
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of CAV1 mRNA17484886
D000068579CelecoxibCelecoxib results in increased expression of CAV1 protein18848576
D020111Chlorodiphenyl (54% Chlorine)Chlorodiphenyl (54% Chlorine) results in decreased expression of CAV1 mRNA23650126
C100187chloropicrinchloropicrin affects the expression of CAV1 mRNA26352163
C100187chloropicrinchloropicrin results in decreased expression of CAV1 mRNA28476498
D002784CholesterolCAV1 protein results in increased transport of Cholesterol12640124
D002784CholesterolCAV1 protein affects the reaction [Cholesterol affects the localization of APOE protein]21169230
D002784CholesterolCholesterol promotes the reaction [APOE protein binds to CAV1 protein]21169230
D002857Chromium[Niacin co-treated with Chromium] inhibits the reaction [CAV1 protein binds to NOS3 protein]19027847
D002857Chromium[Niacin co-treated with Chromium] results in decreased expression of CAV1 protein19027847
C031180chrysene[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA27858113
C031180chrysenechrysene results in decreased expression of CAV1 mRNA26377693
D002939CiprofloxacinCiprofloxacin results in increased expression of CAV1 protein26947806
D002994ClofibrateClofibrate affects the expression of CAV1 protein17961437
D003033Coal TarCoal Tar results in decreased expression of CAV1 mRNA27858113
C007095cobaltiprotoporphyrincobaltiprotoporphyrin inhibits the reaction [IL1B protein results in increased expression of CAV1 mRNA]22155307
C018021cobaltous chloridecobaltous chloride results in decreased expression of CAV1 mRNA19320972
D003345CorticosteroneCorticosterone results in increased expression of CAV1 mRNA23426970
D003375Coumestrol[Coumestrol co-treated with resveratrol] results in increased expression of CAV1 mRNA19167446
D003375CoumestrolCoumestrol results in increased expression of CAV1 mRNA19167446
C015763cumenecumene results in decreased expression of CAV1 mRNA18648096
D003513CycloheximideCycloheximide inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA]15314095
D016572CyclosporineCyclosporine results in decreased expression of CAV1 mRNA20106945|2798913
C089595cylindrospermopsincylindrospermopsin results in increased expression of CAV1 mRNA24921660
C093628cyproconazolecyproconazole results in decreased expression of CAV1 mRNA26238599
D003609DactinomycinDactinomycin inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA]15314095
C014347decitabine[decitabine co-treated with Depsipeptides] results in decreased expression of CAV1 mRNA17064661
C014347decitabinedecitabine results in increased expression of CAV1 mRNA16367923
D003676DeferoxamineDeferoxamine results in increased expression of CAV1 protein16927372
D003676DeferoxamineTRAP1 protein inhibits the reaction [Deferoxamine results in increased expression of CAV1 protein]16927372
D047630Depsipeptides[decitabine co-treated with Depsipeptides] results in decreased expression of CAV1 mRNA17064661
D003907DexamethasoneDexamethasone results in increased expression of CAV1 mRNA23426970
D003907DexamethasoneDexamethasone results in increased expression of CAV1 protein23426970
D003907DexamethasoneMifepristone inhibits the reaction [Dexamethasone results in increased expression of CAV1 mRNA]23426970
D003907DexamethasoneSpironolactone inhibits the reaction [Dexamethasone results in increased expression of CAV1 mRNA]23426970
D003907DexamethasoneDexamethasone results in increased expression of CAV1 mRNA25047013
D003907DexamethasoneDexamethasone results in increased expression of CAV1 protein23426970
D003907Dexamethasone[Dexamethasone results in increased expression of CAV1 protein] which results in decreased susceptibility to VEGFA protein23426970
D003907Dexamethasone[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CAV1 mRNA16054899
D003907Dexamethasone[octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein14984747
D003907Dexamethasone[SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein]14984747
C028009diallyl disulfidediallyl disulfide promotes the reaction [NOS3 protein binds to CAV1 protein]20229525
C042577diallyl trisulfidediallyl trisulfide promotes the reaction [NOS3 protein binds to CAV1 protein]20229525
D003993Dibutyl PhthalateDibutyl Phthalate results in decreased expression of CAV1 mRNA21266533
D002945CisplatinCAV1 protein affects the susceptibility to Cisplatin16217747
D002945CisplatinCisplatin results in increased expression of CAV1 mRNA27392435
D002945CisplatinCisplatin affects the expression of CAV1 mRNA21151649
D002945CisplatinCisplatin results in decreased expression of CAV1 mRNA22023808
D004041Dietary FatsDietary Fats affects the expression of CAV1 mRNA19680557
D004041Dietary FatsDietary Fats results in decreased expression of CAV1 mRNA22609946
D004041Dietary FatsDietary Fats results in increased expression of CAV1 mRNA19030233
D004041Dietary Fatsrimonabant inhibits the reaction [Dietary Fats results in increased expression of CAV1 mRNA]19030233
D004041Dietary Fats[Dietary Sucrose co-treated with Dietary Fats] results in increased expression of CAV1 mRNA23529981
D019422Dietary Sucrose[Dietary Sucrose co-treated with Dietary Fats] results in increased expression of CAV1 mRNA23529981
D004051Diethylhexyl PhthalateDiethylhexyl Phthalate results in decreased expression of CAV1 mRNA27614199
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of CAV1 mRNA21527772
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of CAV1 mRNA24535843
D004054DiethylstilbestrolDiethylstilbestrol results in increased expression of CAV1 mRNA21658437
D002117CalcitriolCalcitriol results in increased localization of [VDR protein co-treated with CAV1 protein]20371703
D004128DimethylnitrosamineDimethylnitrosamine promotes the reaction [CAV1 protein binds to NOS3 protein]18364076
D004128DimethylnitrosamineDimethylnitrosamine results in increased expression of CAV1 mRNA25380136
D004128DimethylnitrosamineDimethylnitrosamine results in increased expression of CAV1 protein18364076
D004237DiuronDiuron results in decreased expression of CAV1 mRNA21551480|2515243
D004281Docosahexaenoic AcidsDocosahexaenoic Acids results in increased expression of CAV1 protein15560787
C012301domoic aciddomoic acid results in decreased expression of CAV1 mRNA18936300
D004317DoxorubicinCAV1 protein affects the susceptibility to Doxorubicin16217747
D004317DoxorubicinDoxorubicin results in increased expression of CAV1 mRNA22008532
D004317Doxorubicin[CAV1 protein binds to CAV3 protein] promotes the reaction [Doxorubicin results in increased activity of CASP3 protein]17982011
D015118Eicosapentaenoic AcidEicosapentaenoic Acid results in increased expression of CAV1 protein15560787
D060754EquolEquol inhibits the reaction [NOS3 protein binds to CAV1 protein]16840783
D000431EthanolEthanol results in increased expression of CAV1 mRNA15963989
D004997Ethinyl EstradiolEthinyl Estradiol results in decreased expression of CAV1 mRNA17475347
D005020Ethyl MethanesulfonateEthyl Methanesulfonate results in decreased expression of CAV1 mRNA23649840
D011345FenofibrateFenofibrate results in increased expression of CAV1 mRNA15314095
C020748ferrous sulfateferrous sulfate affects the localization of CAV1 protein17172471
D005472FluorouracilCAV1 protein affects the susceptibility to Fluorouracil15352031
D005472FluorouracilFluorouracil results in decreased expression of CAV1 protein15352031
D005557FormaldehydeFormaldehyde results in decreased expression of CAV1 mRNA23649840
C070081fulvestrantfulvestrant inhibits the reaction [Estradiol promotes the reaction [CAV1 protein modified form binds to CAV1 protein]]18296501
C070081fulvestrantfulvestrant inhibits the reaction [Estradiol promotes the reaction [ESR1 protein binds to CAV1 protein]]18296501
C070081fulvestrantfulvestrant inhibits the reaction [Estradiol promotes the reaction [ESR1 protein modified form binds to CAV1 protein]]18296501
C070081fulvestrantfulvestrant inhibits the reaction [resveratrol promotes the reaction [CAV1 protein modified form binds to CAV1 protein]]18296501
C070081fulvestrantfulvestrant inhibits the reaction [resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein]]18296501
C070081fulvestrantfulvestrant inhibits the reaction [resveratrol promotes the reaction [ESR1 protein modified form binds to CAV1 protein]]18296501
C070081fulvestrantfulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of CAV1 mRNA]17091190
C070081fulvestrantfulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of CAV1 protein]17091190
C039281furanfuran results in increased expression of CAV1 mRNA27387713
C419708gefitinibgefitinib results in increased expression of CAV1 mRNA19288272
C419708gefitinibgefitinib results in increased expression of CAV1 protein19288272
D019833GenisteinGenistein results in decreased expression of CAV1 mRNA22228119
C017338geranylgeraniolgeranylgeraniol inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA]15314095
D005947GlucoseEGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]19816600
D005947GlucoseGlucose results in decreased expression of CAV1 mRNA19816600
D005947GlucoseGlucose results in decreased expression of CAV1 protein19816600
D005947GlucoseSimvastatin inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]19816600
D005947GlucoseGlucose results in increased expression of CAV1 mRNA22983702
D005947Glucoseresveratrol inhibits the reaction [Glucose results in increased expression of CAV1 mRNA]22983702
D005947GlucoseSemaxinib inhibits the reaction [Glucose results in increased expression of CAV1 mRNA]22983702
C071834glycidamideglycidamide results in decreased expression of CAV1 mRNA17822822
D006575Heterocyclic Compounds, 3-Ring"Heterocyclic Compounds, 3-Ring results in decreased expression of CAV1 mRNA"26833564
D006854HydrocortisoneHydrocortisone results in increased expression of CAV1 mRNA23426970
D006861Hydrogen PeroxideCAV1 protein results in increased susceptibility to Hydrogen Peroxide12640124
D006861Hydrogen PeroxideHydrogen Peroxide inhibits the reaction [Acetylcysteine results in increased ubiquitination of and results in increased degradation of CAV1 protein]21148404
D006861Hydrogen PeroxideHydrogen Peroxide promotes the reaction [CAVIN1 protein binds to CAV1 protein]21705337
D006861Hydrogen PeroxideHydrogen Peroxide promotes the reaction [SIRT1 protein binds to CAV1 protein]25512378
D006861Hydrogen PeroxideHydrogen Peroxide results in increased expression of CAV1 mRNA18385095
D006861Hydrogen PeroxideHydrogen Peroxide results in increased expression of CAV1 protein18385095
D006861Hydrogen PeroxideHydrogen Peroxide results in increased phosphorylation of CAV1 protein23246481|2551237
D006861Hydrogen PeroxideQuercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 mRNA]18385095
D006861Hydrogen PeroxideQuercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein]18385095
D006861Hydrogen PeroxideSB 203580 inhibits the reaction [Hydrogen Peroxide promotes the reaction [SP1 protein results in increased expression of CAV1 protein]]17108117
D006861Hydrogen PeroxideSB 203580 inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of CAV1 protein]25512378
D006861Hydrogen Peroxidewogonin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of CAV1 protein]23246481
D006861Hydrogen Peroxidewortmannin inhibits the reaction [CAV1 protein results in increased susceptibility to Hydrogen Peroxide]12640124
D006861Hydrogen PeroxideCAV1 gene mutant form inhibits the reaction [Hydrogen Peroxide results in increased acetylation of TRP53 protein]25512378
D006861Hydrogen PeroxideCAV1 protein affects the reaction [Hydrogen Peroxide results in increased expression of and results in increased secretion of IL6 protein]25512378
D006861Hydrogen PeroxideCAV1 protein affects the reaction [Hydrogen Peroxide results in increased expression of IL6 mRNA]25512378
D006861Hydrogen PeroxideCAVIN1 protein affects the reaction [Hydrogen Peroxide promotes the reaction [MDM1 protein binds to CAV1 protein]]21705337
D006861Hydrogen Peroxide[Hydrogen Peroxide co-treated with CAV1 protein] results in increased expression of CDKN1A protein25512378
D006861Hydrogen PeroxideHydrogen Peroxide promotes the reaction [MDM1 protein binds to CAV1 protein]21705337
D006861Hydrogen PeroxideHydrogen Peroxide promotes the reaction [SP1 protein binds to CAV1 promoter]17108117
D006861Hydrogen PeroxideHydrogen Peroxide promotes the reaction [SP1 protein results in increased expression of CAV1 protein]17108117
D006861Hydrogen PeroxideHydrogen Peroxide results in increased expression of CAV1 mRNA12134086
D006861Hydrogen PeroxideHydrogen Peroxide results in increased expression of CAV1 protein12134086|1710811
D006861Hydrogen PeroxideQuercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein]12134086|1710811
D006861Hydrogen PeroxideSB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein]17108117
D006861Hydrogen PeroxideSIRT1 mutant form inhibits the reaction [CAV1 gene mutant form inhibits the reaction [Hydrogen Peroxide results in increased acetylation of TRP53 protein]]25512378
D006861Hydrogen PeroxideSIRT1 protein affects the reaction [CAV1 protein affects the reaction [Hydrogen Peroxide results in increased expression of IL6 mRNA]]25512378
D006861Hydrogen PeroxideTRP53 gene mutant form inhibits the reaction [[Hydrogen Peroxide co-treated with CAV1 protein] results in increased expression of CDKN1A protein]25512378
D006861Hydrogen PeroxideVitamin E inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein]12134086
D015759IonomycinIonomycin inhibits the reaction [NOX2 protein binds to CAV1 protein]24835767
D007501IronIron affects the localization of CAV1 protein17172471
D0150561-Methyl-3-isobutylxanthine[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CAV1 mRNA16054899
D007545IsoproterenolCAV1 protein promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein]18820136
C561695(+)-JQ1 compound(+)-JQ1 compound results in decreased expression of CAV1 mRNA24796395|2596192
C008261lead acetatelead acetate results in decreased expression of CAV1 mRNA11578147
C008261lead acetatelead acetate results in increased expression of CAV1 mRNA22641619
C533894LG 100815LG 100815 results in decreased expression of CAV1 mRNA16951191
C440499lipopolysaccharide, Escherichia coli O111 B4"[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] affects the localization of CAV1 protein"20060843
C440499lipopolysaccharide, Escherichia coli O111 B4"methyl-beta-cyclodextrin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] affects the localization of CAV1 protein]"20060843
C440499lipopolysaccharide, Escherichia coli O111 B4"Quercetin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] affects the localization of CAV1 protein]"20060843
D008070LipopolysaccharidesCAV1 mutant form promotes the reaction [Lipopolysaccharides results in increased expression of NOX1 mRNA]24835767
D008070LipopolysaccharidesCAV1 mutant form promotes the reaction [Lipopolysaccharides results in increased expression of NOX2 mRNA]24835767
D008070LipopolysaccharidesCAV1 mutant form promotes the reaction [Lipopolysaccharides results in increased expression of NOX4 mRNA]24835767
D008070LipopolysaccharidesLipopolysaccharides results in increased expression of CAV1 protein modified form26357463
D008070LipopolysaccharidesLipopolysaccharides results in increased phosphorylation of and affects the localization of CAV1 protein26357463
D008070LipopolysaccharidesCAV1 gene mutant form promotes the reaction [Lipopolysaccharides results in increased expression of NOX2 mRNA]24835767
D008070LipopolysaccharidesCAV1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of NOX2 mRNA]24835767
D008070LipopolysaccharidesLipopolysaccharides affects the expression of CAV1 mRNA10948129
D008070LipopolysaccharidesLipopolysaccharides affects the expression of CAV1 protein10948129
D008070Lipopolysaccharides"4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of CAV1 protein]"26357463
D008070LipopolysaccharidesAG 1879 inhibits the reaction [Lipopolysaccharides results in increased expression of CAV1 protein modified form]26357463
D008070LipopolysaccharidesAG 1879 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of CAV1 protein]26357463
D008070LipopolysaccharidesLipopolysaccharides results in increased expression of CAV1 protein modified form26357463
D008070LipopolysaccharidesLipopolysaccharides results in increased phosphorylation of and affects the localization of CAV1 protein26357463
D008070Lipopolysaccharidesmethyl-beta-cyclodextrin inhibits the reaction [Lipopolysaccharides results in increased expression of CAV1 protein modified form]26357463
D008070LipopolysaccharidesQuercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of CAV1 protein]26357463
D008070Lipopolysaccharidessaracatinib inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of CAV1 protein]26357463
D008095Lithocholic AcidLithocholic Acid results in increased localization of [VDR protein co-treated with CAV1 protein]20371703
C502354lithocholic acid acetatelithocholic acid acetate results in increased localization of [VDR protein co-treated with CAV1 protein]20371703
D008244Lysophosphatidylcholinesalpha-Tocopherol inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA]27257344
D008244LysophosphatidylcholinesLysophosphatidylcholines results in increased expression of CAV1 mRNA27257344
D008244LysophosphatidylcholinesLysophosphatidylcholines results in increased expression of CAV1 protein27257344
D008244Lysophosphatidylcholinesquercetin 3-O-glucuronide inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA]27257344
D008244LysophosphatidylcholinesQuercetin inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA]27257344
D008244LysophosphatidylcholinesQuercetin inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 protein]27257344
D008345ManganeseManganese results in decreased expression of CAV1 mRNA23499988|2359785
D008345ManganeseManganese results in decreased expression of CAV1 protein23597857
C042720mercuric bromidemercuric bromide results in increased expression of CAV1 mRNA26272509
C042720mercuric bromide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA"27188386
D008727MethotrexateCAV1 mRNA affects the susceptibility to Methotrexate22753658
D008727MethotrexateCAV1 mRNA results in decreased susceptibility to Methotrexate18694510
D008727MethotrexateMethotrexate results in increased expression of CAV1 mRNA21678067
D008731MethoxychlorMethoxychlor results in increased methylation of CAV1 gene23303685
C108732methyl-beta-cyclodextrinmethyl-beta-cyclodextrin inhibits the reaction [Estradiol promotes the reaction [CAV1 protein modified form binds to CAV1 protein]]18296501
C108732methyl-beta-cyclodextrinmethyl-beta-cyclodextrin inhibits the reaction [Estradiol promotes the reaction [ESR1 protein binds to CAV1 protein]]18296501
C108732methyl-beta-cyclodextrinmethyl-beta-cyclodextrin inhibits the reaction [Estradiol promotes the reaction [SRC protein modified form binds to CAV1 protein]]18296501
C108732methyl-beta-cyclodextrinmethyl-beta-cyclodextrin inhibits the reaction [resveratrol promotes the reaction [CAV1 protein modified form binds to CAV1 protein]]18296501
C108732methyl-beta-cyclodextrinmethyl-beta-cyclodextrin inhibits the reaction [resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein]]18296501
C108732methyl-beta-cyclodextrinmethyl-beta-cyclodextrin inhibits the reaction [resveratrol promotes the reaction [SRC protein modified form binds to CAV1 protein]]18296501
C108732methyl-beta-cyclodextrin"methyl-beta-cyclodextrin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] affects the localization of CAV1 protein]"20060843
C108732methyl-beta-cyclodextrinmethyl-beta-cyclodextrin inhibits the reaction [Lipopolysaccharides results in increased expression of CAV1 protein modified form]26357463
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in decreased expression of CAV1 mRNA23649840
C043243methyl tert-butyl ethermethyl tert-butyl ether affects the expression of CAV1 mRNA24128854
D015735MifepristoneMifepristone inhibits the reaction [Aldosterone results in increased expression of CAV1 mRNA]23426970
D015735MifepristoneMifepristone inhibits the reaction [Dexamethasone results in increased expression of CAV1 mRNA]23426970
D015735MifepristoneMifepristone inhibits the reaction [Progesterone results in increased expression of CAV1 mRNA]15674352
C523184mocetinostatmocetinostat results in increased expression of CAV1 mRNA27255383
D016686MonocrotalineMonocrotaline results in decreased expression of CAV1 mRNA24835767
D016686MonocrotalineMonocrotaline results in decreased expression of CAV1 protein24835767
C523799MRK 003MRK 003 results in decreased expression of CAV1 mRNA21169257
C080955N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamideN-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of CAV1 protein18848576
C104820N-(3-(aminomethyl)benzyl)acetamidineN-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Oxygen deficiency results in increased expression of CAV1 protein]18717816
C064769N-acetylsphingosineN-acetylsphingosine inhibits the reaction [CAV1 protein results in increased phosphorylation of AKT1 protein]12640124
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of CAV1 mRNA"21624382|2555468
C005274naringinnaringin affects the reaction [IL1B protein affects the expression of CAV1 protein]25632752
D009525Niacin[Niacin co-treated with Chromium] inhibits the reaction [CAV1 protein binds to NOS3 protein]19027847
D009525Niacin[Niacin co-treated with Chromium] results in decreased expression of CAV1 protein19027847
C119536nickel acetateNFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of CAV1 mRNA]23023193
C119536nickel acetatenickel acetate results in increased expression of CAV1 mRNA23023193
C012655nimesulidenimesulide results in increased expression of CAV1 protein18848576
D009569Nitric OxideNitric Oxide results in decreased ubiquitination of and results in decreased degradation of CAV1 protein19706615
D009569Nitric OxideNitric Oxide results in increased expression of CAV1 protein19706615
D009569Nitric OxideNitric Oxide results in increased metabolism of and results in increased stability of CAV1 protein19706615
D009569Nitric Oxide[resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]] which results in increased abundance of Nitric Oxide18296501
C007350nitrofennitrofen results in decreased expression of CAV1 mRNA25078423
C007350nitrofennitrofen results in decreased expression of CAV1 protein25078423
D009599NitroprussideNitroprusside results in decreased ubiquitination of and results in decreased degradation of CAV1 protein19706615
D009599NitroprussideNitroprusside results in increased expression of CAV1 protein19706615
D009599NitroprussideNitroprusside results in increased metabolism of and results in increased stability of CAV1 protein19706615
D009761NystatinNystatin inhibits the reaction [Quercetin affects the localization of CAV1 protein]17876056
C062198octa-2,4,6-trienoic acid"octa-2,4,6-trienoic acid results in decreased expression of CAV1 mRNA"16951191
C031492octanoic acid[octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein14984747
C031492octanoic acid[SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein]14984747
C030110oxaliplatin[oxaliplatin co-treated with Topotecan] results in increased expression of CAV1 mRNA25729387
C030110oxaliplatinoxaliplatin results in increased expression of CAV1 mRNA25729387
D010100OxygenN-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Oxygen deficiency results in increased expression of CAV1 protein]18717816
D010100Oxygen"[Oxygen deficiency co-treated with 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene] results in increased expression of CAV1 protein"18717816
D010100OxygenOxygen deficiency results in increased expression of CAV1 mRNA18717816
D010100OxygenOxygen deficiency results in increased expression of CAV1 protein18717816
D010100OxygenCAV1 gene mutant form results in increased susceptibility to Oxygen deficiency24835767
D010100Oxygen[CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency] which results in increased expression of NOX2 mRNA24835767
D010100Oxygen[CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency] which results in increased expression of NOX2 protein24835767
D010100Oxygen[CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency] which results in increased expression of NOX4 mRNA24835767
D010100Oxygen[CAV1 gene mutant form results in increased susceptibility to Oxygen deficiency] which results in increased expression of NOX4 protein24835767
D010100Oxygen[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV1 mRNA24835767
D010100Oxygen[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV1 protein16698853|2483576
D010100OxygenSimvastatin inhibits the reaction [[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV1 protein]16698853
D010126OzoneOzone results in decreased expression of CAV1 mRNA12763052
D010126OzoneOzone results in decreased expression of CAV1 protein18207479
D010126OzoneTNF protein affects the reaction [Ozone results in decreased expression of CAV1 protein]18207479
D017239PaclitaxelCAV1 mRNA results in increased susceptibility to Paclitaxel16322897
D010269ParaquatParaquat results in increased expression of CAV1 mRNA26813466
D010269ParaquatParaquat results in increased expression of CAV1 protein26813466
D052638Particulate Matter[CAV1 gene mutant form affects the susceptibility to Particulate Matter] which results in decreased expression of CAV1 mRNA21222557|2122255
C058305phenethyl isothiocyanatephenethyl isothiocyanate results in decreased expression of CAV1 mRNA26678675
D010634PhenobarbitalPhenobarbital affects the expression of CAV1 mRNA23091169
D010656Phenylephrine"Sodium, Dietary affects the reaction [CAV1 protein results in increased susceptibility to Phenylephrine]"18178722
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in increased expression of CAV1 mRNA26272509
C004479pimagedinepimagedine results in decreased expression of CAV1 protein19706615
C060836pioglitazonepioglitazone affects the expression of CAV1 protein17961437
C006253pirinixic acid[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CAV1 mRNA19710929
C006253pirinixic acid[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CAV1 mRNA19710929
D010894PiroxicamPiroxicam results in decreased expression of CAV1 mRNA21858171
D028321Plant PreparationsPlant Preparations results in increased expression of CAV1 mRNA24973489
C060540polyhexamethyleneguanidinepolyhexamethyleneguanidine results in decreased expression of CAV1 mRNA27989595
D011189Potassium Chloride"Sodium, Dietary affects the reaction [CAV1 protein results in increased susceptibility to Potassium Chloride]"18178722
D011374ProgesteroneProgesterone results in increased expression of CAV1 mRNA20631399
D011374ProgesteroneMifepristone inhibits the reaction [Progesterone results in increased expression of CAV1 mRNA]15674352
D011374ProgesteroneProgesterone results in increased expression of CAV1 mRNA15674352
D011374Progesterone[Estradiol co-treated with Progesterone] results in decreased expression of CAV1 protein16436525
D011441PropylthiouracilPropylthiouracil results in increased expression of CAV1 mRNA24780913
C573121ProstaCaidProstaCaid results in decreased expression of CAV1 mRNA21468543
C014175pyrazolo(3,4-d)pyrimidine"pyrazolo(3,4-d)pyrimidine analog affects the expression of CAV1 mRNA"21152443
C014175pyrazolo(3,4-d)pyrimidine"pyrazolo(3,4-d)pyrimidine analog affects the expression of CAV1 mRNA"21152443
D011794QuercetinNystatin inhibits the reaction [Quercetin affects the localization of CAV1 protein]17876056
D011794QuercetinQuercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 mRNA]18385095
D011794QuercetinQuercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein]18385095
D011794QuercetinQuercetin inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA]27257344
D011794QuercetinQuercetin inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 protein]27257344
D011794QuercetinQuercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein]12134086|1710811
D011794Quercetin"Quercetin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] affects the localization of CAV1 protein]"20060843
D011794QuercetinQuercetin inhibits the reaction [Quercetin results in increased expression of CAV1 mRNA]12134086
D011794QuercetinQuercetin results in decreased expression of CAV1 protein12134086
D011794QuercetinQuercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of CAV1 protein]26357463
D011794QuercetinQuercetin results in increased expression of CAV1 protein16331104
D011794Quercetin"Quercetin inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of and results in increased phosphorylation of CAV1 protein]"19608276
C443401quercetin 3-O-glucuronidequercetin 3-O-glucuronide inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA]27257344
D020849Raloxifene HydrochlorideRaloxifene Hydrochloride affects the expression of CAV1 mRNA14699072
D020849Raloxifene Hydrochloridefulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of CAV1 mRNA]17091190
D020849Raloxifene Hydrochloridefulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of CAV1 protein]17091190
D020849Raloxifene HydrochlorideRaloxifene Hydrochloride results in increased expression of CAV1 mRNA17091190
D020849Raloxifene HydrochlorideRaloxifene Hydrochloride results in increased expression of CAV1 protein17091190
D020849Raloxifene HydrochlorideRaloxifene Hydrochloride results in increased expression of CAV1 protein16680078
D017382Reactive Oxygen SpeciesReactive Oxygen Species promotes the reaction [CAVIN1 protein binds to CAV1 protein]21705337
C059514resveratrolfulvestrant inhibits the reaction [resveratrol promotes the reaction [CAV1 protein modified form binds to CAV1 protein]]18296501
C059514resveratrolfulvestrant inhibits the reaction [resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein]]18296501
C059514resveratrolfulvestrant inhibits the reaction [resveratrol promotes the reaction [ESR1 protein modified form binds to CAV1 protein]]18296501
C059514resveratrolmethyl-beta-cyclodextrin inhibits the reaction [resveratrol promotes the reaction [CAV1 protein modified form binds to CAV1 protein]]18296501
C059514resveratrolmethyl-beta-cyclodextrin inhibits the reaction [resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein]]18296501
C059514resveratrolmethyl-beta-cyclodextrin inhibits the reaction [resveratrol promotes the reaction [SRC protein modified form binds to CAV1 protein]]18296501
C059514resveratrolresveratrol inhibits the reaction [ESR2 protein binds to CAV1 protein]18296501
C059514resveratrolresveratrol promotes the reaction [CAV1 protein modified form binds to CAV1 protein]18296501
C059514resveratrolresveratrol promotes the reaction [ESR1 protein binds to CAV1 protein]18296501
C059514resveratrolresveratrol promotes the reaction [ESR1 protein modified form binds to CAV1 protein]18296501
C059514resveratrolresveratrol promotes the reaction [SRC protein binds to CAV1 protein]18296501
C059514resveratrolresveratrol promotes the reaction [SRC protein modified form binds to CAV1 protein]18296501
C059514resveratrolCAV1 protein affects the transport of resveratrol19321006
C059514resveratrolCAV1 protein results in increased susceptibility to resveratrol19321006
C059514resveratrol[Coumestrol co-treated with resveratrol] results in increased expression of CAV1 mRNA19167446
C059514resveratrolresveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]18296501
C059514resveratrol[resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]] which results in increased abundance of Nitric Oxide18296501
C059514resveratrolresveratrol results in increased expression of CAV1 protein19321006
C059514resveratrolresveratrol results in increased phosphorylation of CAV1 protein18296501
C059514resveratrolresveratrol inhibits the reaction [Streptozocin promotes the reaction [CAV1 protein binds to NOS3 protein]]18266981
C059514resveratrolresveratrol inhibits the reaction [Streptozocin results in increased expression of CAV1 protein]18266981
C059514resveratrolresveratrol results in decreased expression of CAV1 protein18266981
C059514resveratrolresveratrol inhibits the reaction [Glucose results in increased expression of CAV1 mRNA]22983702
C089032rimonabantrimonabant affects the expression of CAV1 mRNA19030233
C089032rimonabantrimonabant inhibits the reaction [Dietary Fats results in increased expression of CAV1 mRNA]19030233
C089730rosiglitazone"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone results in increased expression of CAV1 protein]"16806087
C089730rosiglitazone2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA]15314095
C089730rosiglitazoneAcetylcysteine inhibits the reaction [rosiglitazone results in increased expression of CAV1]18507034
C089730rosiglitazoneCycloheximide inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA]15314095
C089730rosiglitazoneDactinomycin inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA]15314095
C089730rosiglitazonegeranylgeraniol inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA]15314095
C089730rosiglitazonerosiglitazone results in increased expression of CAV118507034
C089730rosiglitazonerosiglitazone results in increased expression of CAV1 mRNA15314095|1638671
C089730rosiglitazonerosiglitazone results in increased expression of CAV1 protein15314095|1638671
C089730rosiglitazonetyrphostin AG 1478 inhibits the reaction [rosiglitazone results in increased expression of CAV1]18507034
C089730rosiglitazone[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CAV1 mRNA16054899
C089730rosiglitazonerosiglitazone results in increased expression of CAV1 mRNA17245590
C515233saracatinibsaracatinib inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of CAV1 protein]26357463
C093642SB 203580SB 203580 inhibits the reaction [Hydrogen Peroxide promotes the reaction [SP1 protein results in increased expression of CAV1 protein]]17108117
C093642SB 203580SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of CAV1 protein]25512378
C093642SB 203580SB 203580 inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of CAV1 mRNA]21457723
C093642SB 203580SB 203580 inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of CAV1 protein]21457723
C093642SB 203580SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein]17108117
C093642SB 203580[SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein]14984747
C410733scriptaidscriptaid affects the expression of CAV1 mRNA18813790
C116890Semaxinib[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV1 mRNA24835767
C116890Semaxinib[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV1 protein16698853|2483576
C116890SemaxinibSimvastatin inhibits the reaction [[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV1 protein]16698853
C116890SemaxinibSemaxinib inhibits the reaction [Glucose results in increased expression of CAV1 mRNA]22983702
D012822Silicon DioxideSilicon Dioxide analog results in increased expression of CAV1 mRNA25895662
D019821SimvastatinSimvastatin inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]19816600
D019821SimvastatinSimvastatin promotes the reaction [[APOA4 protein co-treated with CBS protein] affects the expression of CAV1 protein]18224302
D019821SimvastatinSimvastatin results in decreased expression of CAV1 protein18224302
D019821SimvastatinSimvastatin inhibits the reaction [[Semaxinib co-treated with Oxygen deficiency] results in decreased expression of CAV1 protein]16698853
C017947sodium arseniteAKT1 mutant form inhibits the reaction [CAV1 protein results in increased susceptibility to sodium arsenite]12640124
C017947sodium arseniteCAV1 protein results in increased susceptibility to sodium arsenite12640124
C017947sodium arsenitewortmannin inhibits the reaction [CAV1 protein results in increased susceptibility to sodium arsenite]12640124
C017947sodium arsenitesodium arsenite results in decreased expression of CAV1 mRNA16014739
C017947sodium arsenitesodium arsenite results in increased expression of CAV1 protein17123562
C017947sodium arsenitesodium arsenite results in increased expression of CAV1 protein19072884
D012982Sodium, Dietary"Sodium, Dietary affects the reaction [CAV1 gene mutant form results in increased expression of NOS3 mRNA]"18178722
D012982Sodium, Dietary"Sodium, Dietary affects the reaction [CAV1 gene mutant form results in increased expression of NOS3 protein]"18178722
D012982Sodium, Dietary"Sodium, Dietary affects the reaction [CAV1 protein affects the susceptibility to Acetylcholine]"18178722
D012982Sodium, Dietary"Sodium, Dietary affects the reaction [CAV1 protein results in increased susceptibility to Phenylephrine]"18178722
D012982Sodium, Dietary"Sodium, Dietary affects the reaction [CAV1 protein results in increased susceptibility to Potassium Chloride]"18178722
D012999SomanSoman results in increased expression of CAV1 mRNA19281266
D053260SootSoot results in decreased expression of CAV1 mRNA22461453
D013109SphingomyelinsCAV1 protein results in increased cleavage of Sphingomyelins12640124
D013111Spider VenomsSpider Venoms results in increased expression of and results in decreased phosphorylation of CAV1 protein27060202
D013148SpironolactoneSpironolactone inhibits the reaction [Aldosterone results in increased expression of CAV1 mRNA]23426970
D013148SpironolactoneSpironolactone inhibits the reaction [Dexamethasone results in increased expression of CAV1 mRNA]23426970
D013311Streptozocinresveratrol inhibits the reaction [Streptozocin promotes the reaction [CAV1 protein binds to NOS3 protein]]18266981
D013311Streptozocinresveratrol inhibits the reaction [Streptozocin results in increased expression of CAV1 protein]18266981
D013311StreptozocinStreptozocin promotes the reaction [CAV1 protein binds to NOS3 protein]18266981
D013311StreptozocinStreptozocin results in increased expression of CAV1 protein18266981
D010042OuabainOuabain results in decreased expression of CAV1 mRNA28795476
D012460Sulfasalazine4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[Sulfasalazine results in decreased activity of SLC7A11 protein] which results in increased expression of CAV1 mRNA]19015640
D012460Sulfasalazine[Sulfasalazine results in decreased activity of SLC7A11 protein] which results in increased expression of CAV1 mRNA19015640
C013698tallowtallow affects the expression of CAV1 mRNA19680557
D013629TamoxifenTamoxifen affects the expression of CAV1 mRNA14699072
D013629TamoxifenTamoxifen results in increased expression of CAV1 protein19288272
D013656Taurocholic AcidCAV1 protein results in increased secretion of Taurocholic Acid14647059
D013739Testosterone[FSHB protein co-treated with Testosterone] results in decreased expression of CAV1 mRNA18535249
D013739Testosterone[PRKACA protein mutant form co-treated with Testosterone] results in decreased expression of CAV1 mRNA18535249
C020806tetrabromobisphenol Atetrabromobisphenol A results in decreased expression of CAV1 mRNA25172293
D013749Tetrachlorodibenzodioxin[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CAV1 mRNA19619570
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of CAV1 mRNA22298810
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of CAV1 mRNA19619570|2010694
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin co-treated with TIPARP gene mutant form] results in increased expression of CAV1 mRNA25975270
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of CAV1 mRNA28238261
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of CAV1 mRNA22298810
D013806TheophyllineTheophylline results in increased expression of CAV1 mRNA16083514
D013853ThioacetamideThioacetamide results in increased expression of CAV1 mRNA23411599
C009495titanium dioxidetitanium dioxide results in decreased expression of CAV1 mRNA23557971|2776080
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in decreased expression of CAV1 mRNA28065790
D014028Tobacco Smoke PollutionCAVIN1 protein affects the reaction [Tobacco Smoke Pollution promotes the reaction [MDM2 protein binds to CAV1 protein]]21705337
D014028Tobacco Smoke PollutionTobacco Smoke Pollution promotes the reaction [CAVIN1 protein binds to CAV1 protein]21705337
D014028Tobacco Smoke PollutionTobacco Smoke Pollution promotes the reaction [MDM2 protein binds to CAV1 protein]21705337
D019772Topotecan[oxaliplatin co-treated with Topotecan] results in increased expression of CAV1 mRNA25729387
D014118Toxins, Biological"Toxins, Biological affects the expression of CAV1 mRNA"19682533
C496197trans-10,cis-12-conjugated linoleic acid"trans-10,cis-12-conjugated linoleic acid results in decreased expression of CAV1 mRNA"15888570
D014212TretinoinTretinoin results in increased expression of CAV1 mRNA15977162
D014212TretinoinTretinoin results in decreased expression of CAV1 mRNA21934132
C032910triadimefontriadimefon analog results in decreased expression of CAV1 mRNA26238599
C032910triadimefontriadimefon results in decreased expression of CAV1 mRNA26238599|2670570
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA"27188386
C012589trichostatin Atrichostatin A results in increased expression of CAV1 mRNA24935251|2623859
C012589trichostatin Atrichostatin A results in decreased expression of CAV1 mRNA15901671
C015559trimellitic anhydridetrimellitic anhydride results in decreased expression of CAV1 mRNA19042947
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of CAV1 mRNA"26179874
C057693troglitazonetroglitazone results in decreased expression of CAV1 mRNA21515302
C079836tyrphostin 25tyrphostin 25 inhibits the reaction [arsenite results in increased phosphorylation of CAV1 protein]14511371
C079836tyrphostin 25tyrphostin 25 inhibits the reaction [INS1 protein results in increased phosphorylation of CAV1 protein]14511371
C101044tyrphostin AG 1478tyrphostin AG 1478 inhibits the reaction [rosiglitazone results in increased expression of CAV1]18507034
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAV1 mRNA"27188386
D014635Valproic AcidValproic Acid affects the expression of CAV1 mRNA25979313
D014635Valproic AcidValproic Acid results in decreased expression of CAV1 mRNA29154799
D014635Valproic AcidValproic Acid results in decreased methylation of CAV1 gene29154799
D014635Valproic AcidValproic Acid results in increased expression of CAV1 mRNA23179753|2438349
D014635Valproic AcidValproic Acid results in decreased expression of CAV1 mRNA15901671
D001335Vehicle Emissions[CAV1 gene mutant form affects the susceptibility to Vehicle Emissions] which results in decreased expression of CAV1 mRNA21222557|2122255
D001335Vehicle EmissionsVehicle Emissions results in decreased methylation of CAV1 gene25560391
D014800VitalliumVitallium analog results in decreased expression of CAV1 mRNA23825117
D014810Vitamin EVitamin E inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein]12134086
C111237vorinostatvorinostat results in increased expression of CAV1 mRNA26272509
C085514wogoninwogonin inhibits the reaction [Anisomycin results in increased phosphorylation of CAV1 protein]23246481
C085514wogoninwogonin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of CAV1 protein]23246481
C009687wortmanninwortmannin inhibits the reaction [CAV1 protein results in increased susceptibility to Hydrogen Peroxide]12640124
C009687wortmanninwortmannin inhibits the reaction [CAV1 protein results in increased susceptibility to sodium arsenite]12640124

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005102signaling receptor binding-IPI16890161  
GO:0005113patched binding-NAS11278759  
GO:0005198structural molecule activity-IBA21873635  
GO:0005198structural molecule activity-IDA11865038  
GO:0005515protein binding-IPI8621645  10212252  11075810  11112773  11294831  12176037  
15182174  15504032  15657067  15703204  16388599  16799092  
16890161  16951145  17287217  17848177  17855368  18923542  
19052258  19262564  19706440  19820694  19897728  19931615  
20808760  20826780  20956295  21382479  21822278  22277751  
22411794  23339905  24013648  24089527  24625804  24658140  
25285302  25556234  25588833  25893292  
GO:0015485cholesterol binding-TAS11294831  
GO:0016504peptidase activator activity-ISS-  
GO:0019899enzyme binding-IPI20122998  
GO:0019901protein kinase binding-IBA21873635  
GO:0019901protein kinase binding-IPI25006397  
GO:0030674protein binding, bridging-IEA-  
GO:0032947protein-containing complex scaffold activity-IBA21873635  
GO:0032947protein-containing complex scaffold activity-TAS19052258  
GO:0042802identical protein binding-IPI25006397  
GO:0044325ion channel binding-IBA21873635  
GO:0044325ion channel binding-IPI18923542  
GO:0046982protein heterodimerization activity-IEA-  
GO:0048365Rac GTPase binding-IPI24625804  
GO:0050998nitric-oxide synthase binding-IPI12852865  
GO:0051117ATPase binding-IPI24089527  
GO:0070320inward rectifier potassium channel inhibitor activity-IDA18923542  
GO ID GO Term Qualifier Evidence PubMed
GO:0000122negative regulation of transcription by RNA polymerase II-ISS-  
GO:0000188inactivation of MAPK activity-ISS-  
GO:0001525angiogenesis-IEA-  
GO:0001570vasculogenesis-ISS-  
GO:0001666response to hypoxia-ISS-  
GO:0001937negative regulation of endothelial cell proliferation-IBA21873635  
GO:0001937negative regulation of endothelial cell proliferation-ISS-  
GO:0001960negative regulation of cytokine-mediated signaling pathway-IEA-  
GO:0002931response to ischemia-IEA-  
GO:0003057regulation of the force of heart contraction by chemical signal-IEA-  
GO:0006641triglyceride metabolic process-ISS-  
GO:0006816calcium ion transport-ISS-  
GO:0006869lipid transport-IBA21873635  
GO:0006874cellular calcium ion homeostasis-IBA21873635  
GO:0006874cellular calcium ion homeostasis-ISS-  
GO:0006940regulation of smooth muscle contraction-ISS-  
GO:0007519skeletal muscle tissue development-ISS-  
GO:0007595lactation-IEA-  
GO:0008104protein localization-ISS-  
GO:0009617response to bacterium-IDA24625804  
GO:0010524positive regulation of calcium ion transport into cytosol-ISS19052258  
GO:0010608posttranscriptional regulation of gene expression-IEA-  
GO:0010628positive regulation of gene expression-IEA-  
GO:0010952positive regulation of peptidase activity-IEA-  
GO:0016050vesicle organization-ISS-  
GO:0019065receptor-mediated endocytosis of virus by host cell-IGI21047970  
GO:0019217regulation of fatty acid metabolic process-ISS-  
GO:0019915lipid storage-ISS-  
GO:0030154cell differentiation-IBA21873635  
GO:0030193regulation of blood coagulation-IMP17848177  
GO:0030301cholesterol transport-TAS11294831  
GO:0030512negative regulation of transforming growth factor beta receptor signaling pathway-IDA25893292  
GO:0030857negative regulation of epithelial cell differentiation-ISS-  
GO:0030879mammary gland development-ISS-  
GO:0031295T cell costimulation-IDA17287217  
GO:0031397negative regulation of protein ubiquitination-IMP22277751  
GO:0031398positive regulation of protein ubiquitination-IMP24089527  
GO:0031623receptor internalization-IDA25893292  
GO:0032091negative regulation of protein binding-IDA16890161  
GO:0032092positive regulation of protein binding-IMP24089527  
GO:0032507maintenance of protein location in cell-ISS-  
GO:0032570response to progesterone-IDA12388746  
GO:0033137negative regulation of peptidyl-serine phosphorylation-IDA18081315  
GO:0033138positive regulation of peptidyl-serine phosphorylation-IDA18081315  
GO:0033484nitric oxide homeostasis-ISS-  
GO:0034141positive regulation of toll-like receptor 3 signaling pathway-IMP25204797  
GO:0042310vasoconstriction-IEA-  
GO:0042532negative regulation of tyrosine phosphorylation of STAT protein-IEA-  
GO:0042632cholesterol homeostasis-ISS-  
GO:0042632cholesterol homeostasis-TAS11294831  
GO:0043085positive regulation of catalytic activity-ISS-  
GO:0043409negative regulation of MAPK cascade-ISS-  
GO:0043627response to estrogen-IDA12388746  
GO:0044860protein localization to plasma membrane raft-ISS-  
GO:0045019negative regulation of nitric oxide biosynthetic process-ISS-  
GO:0045907positive regulation of vasoconstriction-ISS-  
GO:0046426negative regulation of JAK-STAT cascade-ISS-  
GO:0048550negative regulation of pinocytosis-IMP23583380  
GO:0050900leukocyte migration-TAS-  
GO:0050999regulation of nitric-oxide synthase activity-TAS-  
GO:0051001negative regulation of nitric-oxide synthase activity-IEA-  
GO:0051260protein homooligomerization-ISS-  
GO:0051480regulation of cytosolic calcium ion concentration-IDA19052258  
GO:0051592response to calcium ion-ISS19052258  
GO:0051899membrane depolarization-ISS-  
GO:0052547regulation of peptidase activity-ISS-  
GO:0055074calcium ion homeostasis-ISS-  
GO:0060056mammary gland involution-ISS-  
GO:0060355positive regulation of cell adhesion molecule production-IMP25204797  
GO:0060546negative regulation of necroptotic process-IEA-  
GO:0061099negative regulation of protein tyrosine kinase activity-IBA21873635  
GO:0061099negative regulation of protein tyrosine kinase activity-IMP25006397  
GO:0070836caveola assembly-IBA21873635  
GO:0070836caveola assembly-IGI25006397  
GO:0070836caveola assembly-IMP12633858  
GO:0070836caveola assembly-ISS-  
GO:0071360cellular response to exogenous dsRNA-IMP25204797  
GO:0071375cellular response to peptide hormone stimulus-ISS-  
GO:0071455cellular response to hyperoxia-IMP21382479  
GO:0071560cellular response to transforming growth factor beta stimulus-IEA-  
GO:0072584caveolin-mediated endocytosis-IDA19931615  
GO:0086091regulation of heart rate by cardiac conduction-ISS-  
GO:0086098angiotensin-activated signaling pathway involved in heart process-ISS-  
GO:0090090negative regulation of canonical Wnt signaling pathway-ISS-  
GO:0090263positive regulation of canonical Wnt signaling pathway-IMP16890161  
GO:0097190apoptotic signaling pathway-IMP21382479  
GO:0098903regulation of membrane repolarization during action potential-IMP18923542  
GO:0098909regulation of cardiac muscle cell action potential involved in regulation of contraction-IC18923542  
GO:0098911regulation of ventricular cardiac muscle cell action potential-ISS-  
GO:1900027regulation of ruffle assembly-IDA24625804  
GO:1900085negative regulation of peptidyl-tyrosine autophosphorylation-IMP25006397  
GO:1901380negative regulation of potassium ion transmembrane transport-IMP18923542  
GO:1901844regulation of cell communication by electrical coupling involved in cardiac conduction-ISS-  
GO:1903071positive regulation of ER-associated ubiquitin-dependent protein catabolic process-IC24089527  
GO:1903361protein localization to basolateral plasma membrane-ISS-  
GO:1903598positive regulation of gap junction assembly-ISS-  
GO:1903609negative regulation of inward rectifier potassium channel activity-IMP18923542  
GO:1904886beta-catenin destruction complex disassembly-TAS-  
GO:2000286receptor internalization involved in canonical Wnt signaling pathway-IMP16890161  
GO:2000535regulation of entry of bacterium into host cell-IDA24625804  
GO:2000811negative regulation of anoikis-IMP22277751  
GO:2001238positive regulation of extrinsic apoptotic signaling pathway-IMP21382479  
GO:2001244positive regulation of intrinsic apoptotic signaling pathway-IMP21382479  
GO ID GO Term Qualifier Evidence PubMed
GO:0000139Golgi membrane-IDA11294831  
GO:0000139Golgi membrane-TAS-  
GO:0002080acrosomal membrane-IEA-  
GO:0005622intracellular-IDA15703204  
GO:0005737cytoplasmCOLOCALIZES_WITHIBA21873635  
GO:0005768endosome-IDA20682791  
GO:0005783endoplasmic reticulum-IDA11294831  
GO:0005789endoplasmic reticulum membrane-TAS24089527  
GO:0005794Golgi apparatus-IBA21873635  
GO:0005811lipid droplet-TAS-  
GO:0005886plasma membrane-IDA23262137  
GO:0005886plasma membrane-TAS-  
GO:0005887integral component of plasma membrane-IBA21873635  
GO:0005887integral component of plasma membrane-IEA-  
GO:0005901caveolaCOLOCALIZES_WITHIBA21873635  
GO:0005901caveola-IDA15219854  15703204  17982011  18081315  19525939  24013648  25556234  
GO:0005925focal adhesion-HDA21423176  
GO:0005925focal adhesionCOLOCALIZES_WITHIBA21873635  
GO:0005925focal adhesioncolocalizes_withIDA12091389  
GO:0005929cilium-IEA-  
GO:0005938cell cortex-IEA-  
GO:0016020membrane-IDA24625804  
GO:0030666endocytic vesicle membrane-TAS-  
GO:0031410cytoplasmic vesicle-IBA21873635  
GO:0031410cytoplasmic vesicle-IDA19931615  22792322  
GO:0031901early endosome membrane-TAS-  
GO:0032991protein-containing complex-IDA21822278  24013648  
GO:0034098VCP-NPL4-UFD1 AAA ATPase complexcolocalizes_withIPI24089527  
GO:0042383sarcolemmaCOLOCALIZES_WITHIBA21873635  
GO:0045121membrane raft-IDA11294831  14559243  17010968  21382479  23262137  25204797  25893292  
GO:0048471perinuclear region of cytoplasm-IBA21873635  
GO:0048471perinuclear region of cytoplasm-IDA19931615  
GO:0048471perinuclear region of cytoplasm-ISS-  
KEGG ID KEGG Term
hsa04144Endocytosis
hsa04510Focal adhesion
hsa05100Bacterial invasion of epithelial cells
hsa05416Viral myocarditis
Reactome ID Reactome Term Evidence
R-HSA-109582HemostasisTAS
R-HSA-1430728MetabolismTAS
R-HSA-1430728MetabolismIEA
R-HSA-162582Signal TransductionTAS
R-HSA-163560Triglyceride catabolismIEA
R-HSA-194138Signaling by VEGFTAS
R-HSA-195721Signaling by WNTTAS
R-HSA-201681TCF dependent signaling in response to WNTTAS
R-HSA-202131Metabolism of nitric oxideTAS
R-HSA-202733Cell surface interactions at the vascular wallTAS
R-HSA-203615eNOS activationTAS
R-HSA-203641NOSTRIN mediated eNOS traffickingTAS
R-HSA-203765eNOS activation and regulationTAS
R-HSA-210991Basigin interactionsTAS
R-HSA-4420097VEGFA-VEGFR2 PathwayTAS
R-HSA-4641262Disassembly of the destruction complex and recruitment of AXIN to the membraneTAS
R-HSA-5218920VEGFR2 mediated vascular permeabilityTAS
R-HSA-556833Metabolism of lipidsIEA
R-HSA-8979227Triglyceride metabolismIEA
R-HSA-9006934Signaling by Receptor Tyrosine KinasesTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
23482776Functional polymorphism in the CAV1 T29107A gene and its association with prostate cancer risk among Japanese men. (2013 Mar)Sugie SAnticancer Res
27905406Differential Roles for L-Type Calcium Channel Subtypes in Alcohol Dependence. (2017 Apr)Uhrig SNeuropsychopharmacology
28185965Cav1.2, but not Cav1.3, L-type calcium channel subtype mediates nicotine-induced conditioned place preference in miceo. (2017 Apr 3)Liu YProg Neuropsychopharmacol Biol Psychiatry
28497380From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms. (2017 Jul)Kabir ZDNeurotherapeutics
28194001Enhancing VTA Cav1.3 L-type Ca(2+) channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbens. (2017 Dec)Martinez-Rivera AMol Psychiatry
29089442Extinction of Contextual Cocaine Memories Requires Cav1.2 within D1R-Expressing Cells and Recruits Hippocampal Cav1.2-Dependent Signaling Mechanisms. (2017 Dec 6)Burgdorf CEJ Neurosci